| Huang, Jian |
NCT05131841: Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC |
|
|
| Recruiting | 4 | 60 | RoW | Cipterbin Combined With Vinorelbine | Zhejiang Cancer Hospital, Proswell Medical Corporation | Metastatic Breast Cancer | 12/22 | 12/22 | | |
CLOVER, NCT03926091: Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer |
|
|
| Recruiting | 3 | 2172 | RoW | Docetaxel, docetaxel injection, Cyclophosphamide, Cyclophosphamide injection | Fudan University | Breast Cancer | 11/24 | 11/25 | | |
NCT05600322: Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer |
|
|
| Completed | 3 | 158 | RoW | Hexaminolevulinate Hydrochloride, Hexvix, Richard Wolf Photodynamic Diagnostic Equipment (PDD) system, System Blue | Photocure, Jiangsu Yahong Meditech Co., Ltd aka Asieris, Richard Wolf GmbH, Tigermed-Jyton Co., Ltd. | Bladder Cancer | 07/23 | 07/23 | | |
NCT06241755: Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) |
|
|
| Recruiting | 3 | 412 | RoW | BCG for Therapeutic Use, BCG | Chengdu CoenBiotech Co., Ltd, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Non-Muscle Invasive Bladder Cancer | 09/25 | 09/26 | | |
NCT05433480: A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer |
|
|
| Active, not recruiting | 3 | 274 | RoW | BPI-16350, placebo, Fulvestrant | Betta Pharmaceuticals Co., Ltd. | Breast Cancer | 12/23 | 07/25 | | |
| Active, not recruiting | 3 | 654 | Europe, Canada, Japan, US, RoW | Tucatinib, TUKYSA, ONT-380, ARRY-380, Trastuzumab, Herceptin, Herceptin Hylecta, Pertuzumab, Perjeta, Combination product: Trastuzumab + Pertuzumab, Phesgo, Placebo | Seagen Inc., Merck Sharp & Dohme LLC | HER2 Positive Breast Cancer | 05/25 | 10/27 | | |
JSKN003-302, NCT06079983: JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects |
|
|
| Not yet recruiting | 3 | 400 | RoW | JSKN003, Capecitabine tablets, Gemcitabine hydrochloride for injection, Vinorelbine tartrate injection, Paclitaxel for injection (albumin-bound type), Docetaxel injection, Eribulin mesylate injection | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Breast Cancer | 04/25 | 03/29 | | |
| Recruiting | 3 | 314 | RoW | Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502), Control drug: Trastuzumab emtansine (Kadcyla, T-DM1) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Breast Cancer | 07/25 | 01/26 | | |
| Active, not recruiting | 3 | 650 | Europe, Canada, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma | 02/25 | 08/28 | | |
NCT05075512: The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer |
|
|
| Recruiting | 2 | 40 | RoW | anlotinib, fulvestrant, AL3818 | Zhejiang Cancer Hospital | Breast Neoplasm Female | 08/23 | 08/26 | | |
NCT04799847: Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine |
|
|
| Recruiting | 1/2 | 161 | RoW | Catumaxomab | LintonPharm Co.,Ltd. | Bladder Cancer | 11/24 | 11/24 | | |
| Recruiting | 1/2 | 725 | RoW | JSKN003 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Advanced Solid Tumor | 12/24 | 12/26 | | |
|
NCT06001580: A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 36 | RoW | BR101 | Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd | Advanced Solid Tumor | 12/23 | 06/26 | | |
NCT06672263: A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia |
|
|
| Not yet recruiting | 1 | 120 | RoW | TQB3911 tablets | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Chronic Myelogenous Leukemia | 09/26 | 12/26 | | |
NCT05106868: Acupuncture for Patients With Major Depressive Disorder |
|
|
| Not yet recruiting | N/A | 123 | NA | acupuncture | Chengdu University of Traditional Chinese Medicine | Major Depressive Disorder | 12/22 | 06/23 | | |
VR-TSP, NCT06574451: Effectiveness and Safety of Adjuvant Software Based on Virtual Reality for Post-thoracoscopic Surgery Pain |
|
|
| Recruiting | N/A | 215 | RoW | VR-assisted postoperative analgesia | Guangdong Provincial People's Hospital, Guang Dong Liang Zi Health Consulting Co., Ltd, Guang Dong, China., Tianjin Medical University General Hospital, Ruijin Hospital, Maoming People's Hospital | Acute Postoperative Pain, Video-assisted Thoracic Surgery, Virtual Reality | 04/25 | 04/25 | | |
NCT04948528: Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection |
|
|
| Recruiting | N/A | 490 | RoW | Active Comparator: Surgery Pathology or Cystoscopy, Active Comparator: Clinical Diagnosis | AnchorDx Medical Co., Ltd., Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Peking University First Hospital, Peking University Third Hospital, Peking Union Medical College Hospital, The Affiliated Hospital of Qingdao University, First Affiliated Hospital, Sun Yat-Sen University, Sir Run Run Shaw Hospital, The First Affiliated Hospital of Zhengzhou University | Upper Tract Urothelial Carcinoma | 06/23 | 12/23 | | |
NCT04744506: Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy |
|
|
| Not yet recruiting | N/A | 126 | RoW | Tissue Marker Clip, Carbon Nanoparticle Suspension Injection | Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Natural Science Foundation of China | Breast Cancer, Surgery, Lymph Node Metastases | 07/28 | 07/29 | | |
NCT04966949: Lateral Prostate Capsule Sparing Versus Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male |
|
|
| Not yet recruiting | N/A | 100 | RoW | lateral prostate capsule sparing or neurovascular bundles sparing | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, The Seventh Affiliated Hospital, Sun Yat-sen University | Bladder Cancer | 08/23 | 08/23 | | |
ONAC, NCT06155305: Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer |
|
|
| Recruiting | N/A | 58 | RoW | Biopsy | Second Affiliated Hospital, School of Medicine, Zhejiang University | Organoids, Breast Cancer, Neoadjuvant Chemotherapy | 12/25 | 12/25 | | |
NCT06658080: Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer |
|
|
| Recruiting | N/A | 90 | RoW | organoid drug test | Second Affiliated Hospital, School of Medicine, Zhejiang University | Breast Cancer Metastatic, Hydrothorax, Ascites, Organoids, Drug Evaluation | 10/26 | 10/27 | | |
NCT06741540: Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression |
|
|
| Not yet recruiting | N/A | 60 | NA | tDCS | Second Affiliated Hospital, School of Medicine, Zhejiang University | Breast Cancer | 12/26 | 12/26 | | |
NCT04966975: Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy |
|
|
| Not yet recruiting | N/A | 60 | NA | neoadjuvant chemotherapy | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Shantou Central Hospital | Bladder Cancer | 08/22 | 08/22 | | |
NCT04966130: Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder. |
|
|
| Not yet recruiting | N/A | 96 | NA | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University | Muscle-Invasive Bladder Carcinoma | 08/22 | 08/22 | | |
NCT04966962: Establishment and Validation of an Early Diagnostic Model for Bladder Cancer Based on Serum and Urine Metabolomics |
|
|
| Not yet recruiting | N/A | 180 | NA | serum and urine metabolomics | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, The Seventh Affiliated Hospital, Sun Yat-sen University | Bladder Cancer | 08/22 | 08/22 | | |
NCT04958343: Application and Clinical Effectiveness of Pelvic Reconstruction in Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder in the Male |
|
|
| Not yet recruiting | N/A | 100 | RoW | pelvic reconstruction | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, The Seventh Affiliated Hospital, Sun Yat-sen University | Bladder Cancer | 07/23 | 07/23 | | |
NCT04958330: Lateral Prostate Capsule Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male |
|
|
| Not yet recruiting | N/A | 100 | RoW | lateral prostate capsule sparing | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, The Seventh Affiliated Hospital, Sun Yat-sen University | Bladder Cancer | 07/23 | 07/23 | | |
NCT05018429: Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male |
|
|
| Not yet recruiting | N/A | 100 | RoW | nerve sparing | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Shantou Central Hospital | Bladder Cancer | 09/23 | 09/23 | | |
| Chen, Dan |
| Active, not recruiting | 3 | 650 | Europe, Canada, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma | 02/25 | 08/28 | | |
MSC-MucInj, NCT06599346: Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients |
|
|
| Recruiting | N/A | 120 | RoW | Standard Care, MSC Supernatant + Standard Care | The General Hospital of Western Theater Command | Mucositis, Hematopoietic Stem Cell Transplantation, Chemotherapy-Induced Mucositis, Radiation-Induced Mucositis | 09/25 | 09/25 | | |
| Completed | N/A | 150 | Europe | | University College London Hospitals | Cardiovascular Diseases, B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Refractory, B-cell Lymphoma Recurrent, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Diffuse Large B Cell Lymphoma, Cardiotoxicity, Cardiovascular Complication | 03/23 | 05/23 | | |
| Renwick, William |
| Active, not recruiting | 3 | 650 | Europe, Canada, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma | 02/25 | 08/28 | | |
| Xu, Jian |
NCT05830500: Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma |
|
|
| Recruiting | 4 | 360 | RoW | Anlotinib Hydrochloride Capsule | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Medullary Thyroid Cancer | 06/27 | 12/28 | | |
| Recruiting | 2/3 | 240 | Europe, Canada, Japan, US, RoW | EFG PH20 SC, PBO | argenx, argenx BV | Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome | 12/26 | 02/27 | | |
| Recruiting | 2 | 146 | RoW | Sirolimus, rapamycin, Placebo | Chinese SLE Treatment And Research Group, Beijing Municipal Science & Technology Commission, North China Pharmaceutical Group Corporation | Systemic Lupus Erythematosus | 10/24 | 05/25 | | |
NCT05242588: Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA |
|
|
| Recruiting | 2 | 120 | RoW | JS005, Recombinant humanized anti-IL-17A monoclonal antibody injection, Placebo | Shanghai Junshi Bioscience Co., Ltd., Sponsor GmbH | Non-radiographic Axial Spondyloarthritis | 04/23 | 06/23 | | |
NCT06140966: Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma |
|
|
| Recruiting | 2 | 54 | RoW | Daratumumab, Darzalex, Carfilzomib, Kyprolis, Lenalidomide, Revlimid, Dexamethasone, Baycadron, Cisplatin, Platinol, epirubicin, Pharmorubicin, Cyclophosphamide, Cytoxan, Etoposide, Eposin, Melphalan, Alkeran, ASCT, autologous stem cell transplantation, bortezomib, Velcade | Wuhan Union Hospital, China | Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma | 10/26 | 10/27 | | |
NCT05849727: A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis |
|
|
| Recruiting | 2 | 180 | RoW | TQH3821 tablets 200 mg, TQH3821 tablets matching placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Rheumatoid Arthritis | 06/24 | 12/24 | | |
| Suspended | 2 | 279 | Europe, US, RoW | zetomipzomib, KZR-616, placebo, matching placebo | Kezar Life Sciences, Inc. | Lupus Nephritis | 05/26 | 07/26 | | |
NCT05227677: Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes |
|
|
| Active, not recruiting | N/A | 200 | RoW | GA guided anti-diabetic therapy adjustment, current guidelines to adjust treatment | Asahi Kasei Pharma Corporation | Type 2 Diabetes Mellitus | 08/24 | 12/24 | | |
NCT05888545: Clinical Study on a Novel Anti-adhesion Barrier Film |
|
|
| Recruiting | N/A | 1176 | RoW | anti-adhesion diaphragm | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Intrauterine Adhesion | 12/24 | 12/24 | | |
LEFAZAREM, NCT04737343: Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis |
|
|
| Recruiting | N/A | 114 | RoW | Leflunomide, Tuoshu for commericial name, Azathioprine Tablets | Chinese SLE Treatment And Research Group, Shanghai Zhongshan Hospital, Affiliated Hospital of Jilin University, Changchun,China, Second Affiliated Hospital of Nanchang University, The First Affiliated Hospital of Anhui Medical University, Beijing Shijitan Hospital, Capital Medical University, The Affiliated Hospital of Inner Mongolia Medical University, The First Affiliated Hospital of Kunming Medical College, Sichuan Province People's Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University | ANCA Associated Vasculitis, Maintenance Therapy | 11/24 | 12/24 | | |
NCT05866029: Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture |
|
|
| Recruiting | N/A | 2478 | RoW | Denosumab, Teriparatide | Peking Union Medical College Hospital | Osteoporotic Fractures | 09/26 | 09/26 | | |
| Recruiting | N/A | 2000 | RoW | | Peking Union Medical College Hospital | Anti Phospholipid Syndrome | 12/26 | 12/26 | | |
| Liu, Lunfei |
NCT04875169: Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis |
|
|
| Completed | 3 | 336 | Canada, RoW | Core Treatment Active Experimental: SHR0302 Dose#1, Core Treatment Active Experimental: SHR0302 Dose#2, Core Treatment Placebo Comparator: Placebo, Extension Treatment Active Experimental: SHR0302 Dose#1, Extension Treatment Active Experimental: SHR0302 Dose#2 | Reistone Biopharma Company Limited | Atopic Dermatitis | 08/22 | 05/23 | | |
NCT06173284: Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 3 | 510 | RoW | 611, Matching placebo | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Dermatitis, Atopic | 09/25 | 05/26 | | |
NCT06280716: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis |
|
|
| Recruiting | 3 | 430 | RoW | Placebo, Lebrikizumab, LY3650150, Topical Corticosteroid | Eli Lilly and Company | Atopic Dermatitis | 12/25 | 11/26 | | |
| Recruiting | 3 | 189 | RoW | Roflumilast Cream 0.3%, Zoryve, Vehicle cream | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Plaque Psoriasis | 06/25 | 07/25 | | |
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 3 | 552 | RoW | ICP-332 Tablets, ICP-332 Placebo Tablets | Beijing InnoCare Pharma Tech Co., Ltd. | Atopic Dermatitis | 11/26 | 12/26 | | |
| Completed | 2 | 93 | RoW | 611 Q2W, 611 Q4W, Matching placebo, placebo | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Dermatitis, Atopic | 07/23 | 09/23 | | |
| Recruiting | 2 | 159 | Europe, Canada, Japan, US, RoW | GSK1070806 | GlaxoSmithKline | Dermatitis, Atopic | 11/29 | 11/29 | | |
NCT05999799: A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 2 | 199 | Europe, Canada, Japan, US, RoW | GSK1070806, Placebo | GlaxoSmithKline | Dermatitis, Atopic | 10/25 | 01/26 | | |
NCT06718192: A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts. |
|
|
| Not yet recruiting | N/A | 70 | RoW | Bleomycin injection, Cryotherapy | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Verruca Plantaris | 06/25 | 06/25 | | |
| Zhu, Yuefeng |
EPICT, NCT04066764: Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters |
|
|
| Recruiting | 3 | 200 | RoW | Rivaroxaban, Xarelto, Warfarin, coumadin, Nadroparin, Fraxiparin | Second Affiliated Hospital, School of Medicine, Zhejiang University, Sir Run Run Shaw Hospital, Huadong Hospital, Shanghai Zhongshan Hospital, Shanghai 5th People's Hospital, Yantai Yuhuangding Hospital, Anhui Provincial Hospital | Venous Thromboembolism | 10/24 | 10/24 | | |
PLICTS, NCT04067505: Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The Study |
|
|
| Recruiting | 3 | 224 | RoW | Rivaroxaban, Xarelto, Warfarin, coumadin, Nadroparin, Fraxiparin | Second Affiliated Hospital, School of Medicine, Zhejiang University, Sir Run Run Shaw Hospital, Huadong Hospital, Shanghai Zhongshan Hospital, Shanghai 5th People's Hospital, Yantai Yuhuangding Hospital, Anhui Provincial Hospital, Zhejiang Provincial People's Hospital, Zhejiang Hospital | May-Thurner Syndrome | 12/24 | 12/24 | | |
NCT05840991: Effect of Short-term Compression Therapy After Thermal Ablation for Varicose Veins |
|
|
| Recruiting | N/A | 360 | RoW | elastic bandage, compression stocking | The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, China-Japan Union Hospital, Jilin University, Yantai Yuhuangding Hospital, The First Affiliated Hospital of Dalian Medical University, Affiliated Hospital of Shaoxing University, Jiangsu Province Hospital of Traditional Chinese Medicine | Varicose Veins | 11/23 | 12/23 | | |
NCT05914740: Feasibility Study of Ultrasound-guided Functional Remodeling of Lower Extremity Superficial Venous Valve |
|
|
| Recruiting | N/A | 10 | RoW | Ultrasound guided functional remodeling of lower extremity superficial vein valve | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Varicose Veins of Lower Limb | 12/23 | 07/24 | | |
NCT05899478: Suture-mediated Closure System Following Endovascular Peripheral Arterial Procedures |
|
|
| Not yet recruiting | N/A | 136 | RoW | Tyknot® Suture-Mediated Closure System, Perclose® ProGlide Suture-Mediated Closure System | Suzhou Hengruihongyuan Medical Technology Co. LTD | Percutaneous Intervention Via Femoral Artery | 03/24 | 05/24 | | |
| Xu, Jiang |
NCT05701644: Study To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects |
|
|
| Completed | 1 | 36 | RoW | C1K 150mg, C1K 300mg, Placebo with the same volume of C1K 300mg, C1K 600mg, Placebo with the same volume of C1K 600mg, C1K 900mg, Placebo with the same volume of C1K 900mg, C1K 1200mg, Placebo with the same volume of C1K 1200mg | Ensol Bioscience | Healthy | 06/23 | 06/23 | | |
NCT05888545: Clinical Study on a Novel Anti-adhesion Barrier Film |
|
|
| Recruiting | N/A | 1176 | RoW | anti-adhesion diaphragm | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Intrauterine Adhesion | 12/24 | 12/24 | | |
| Zheng, Yichun |
NCT05790122: Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma |
|
|
| Recruiting | N/A | 146 | RoW | | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Carcinoma, Renal Cell, Kidney Neoplasms | 12/25 | 12/25 | | |
| Zhuang, Genying |
NCT06308536: Application of Concentrated Growth Factors in Alveolar Ridge Preservation |
|
|
| Recruiting | N/A | 20 | RoW | bone powder + collagen membrane, bone powder + collagen membrane + CGF membrane, bone powder mixed wih CGF gel + collagen membrane + CGF membrane, bone powder + CGF membrane | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Alveolar Ridge Preservation, Concentrated Growth Factor | 10/24 | 04/25 | | |
